Topic Discussed : 2019 Life Science Predictions: Decoding 5 Incredible Growth OpportunitiesSpeakers : Nitin Naik, Unmesh Lal, Khushbu Jain, Fred Mao & Barbara GilmoreThe Life Science industry is in a state of flux. While recent years have seen the advent of multiple novel technologies—such as IVF, CRISPR-Cas9, virtual clinical trials, and liquid biopsy—the industry today stands at a crossroads with challenges in scaling up and commercializing such technologies. The industry has now come to terms with new, path-breaking life science technologies that are helping make precision healthcare a reality. Chinese investments into the US biopharma industry jumped to $4.5 billion in 2018. An exclusive fireside chat with our US and China analysts will uncover trends in cross-border investments and growth opportunities in these two markets.Key Takeaways:Establish the leading factors that will influence the size and direction of the global life sciences market in 2019Build clarity on technology developments in the global life sciences market in 2018 that will have an impact during 2019Identify the business models used to commercialize and distribute novel life science solutionsDiscover the key growth opportunities and strategic imperatives for companies in 2019For further insights, please join is for the future podcasts and become a member of the Frost & Sullivan’s Leadership Council by emailing us at: [email protected] Related Keywords: Frost & Sullivan, Life Sciences, Predictive Analytics, Big Data, Cancer, Genomics, Diagnostics, Investors, Personalized Medicine HealthcareWebsite: www.frost.com Hosted on Acast. See acast.com/privacy for more information.

Ver todos los episodios